Concepedia

Arianna Ghirardi

AG

Statistics

Publications

18

Citations

916

H-Index

16

Active since

2016

Affiliations

Ospedale Papa Giovanni XXIII(Current)

Azienda Ospedaliero-Universitaria Careggi

University of Milan

Istituti di Ricovero e Cura a Carattere Scientifico

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Arianna Ghirardi is an author at Ospedale Papa Giovanni XXIII specializing in medicine, hematology, and myeloproliferative neoplasms.

Publications per year

2016–2023

18

Publications

18

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 132 citations · Full text

Medicine, Hematology, Pharmacotherapy +6

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

Tiziano Barbui, Arianna Ghirardi, Arianna Masciulli et al. · Leukemia · 2019 · 91 citations · Full text

Medicine, Hematology, Oncology +16

Covid-19 and gender: lower rate but same mortality of severe disease in women—an observational study

Luca Novelli, Arianna Ghirardi, Filippo Russo et al. · BMC Pulmonary Medicine · 2021 · 86 citations · Full text

Social Sciences, Infectious Diseases, Epidemiology +14

A reappraisal of the benefit‐risk profile of hydroxyurea in polycythemia vera: A propensity‐matched study

Tiziano Barbui, Alessandro M. Vannucchi, Guido Finazzi et al. · American Journal of Hematology · 2017 · 83 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +12

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 82 citations · Full text

Medicine, Hematology, Pharmacology +15

1–5 of 18